CIK 0001326110
- Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 431979754
- Phone
- +1 844-696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-22 | Sachs David C. Chief Financial Officer | Option exercise | +40,650 | 320,825 | ||
| 2026-02-22 | Sachs David C. Chief Financial Officer | Shares withheld for taxes | −20,682 | $8.70 | $180K | 300,143 |
| 2026-02-22 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −40,650 | 40,651 | ||
| 2026-02-10 | Sachs David C. Chief Financial Officer | Option exercise | +82,236 | 322,818 | ||
| 2026-02-10 | Sachs David C. Chief Financial Officer | Shares withheld for taxes | −42,643 | $6.93 | $296K | 280,175 |
| 2026-02-10 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −82,236 | 164,474 | ||
| 2025-12-31 | Sachs David C. Chief Financial Officer | Option exercise | +30,397 | 256,017 | ||
| 2025-12-31 | Sachs David C. Chief Financial Officer | Shares withheld for taxes | −15,435 | $1.98 | $31K | 240,582 |
| 2025-12-31 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −30,397 | 45,602 | ||
| 2025-02-22 | Sachs David C. Chief Financial Officer | Option exercise | +40,650 | 241,480 | ||
| 2025-02-22 | Sachs David C. Chief Financial Officer | Shares withheld for taxes | −15,860 | $3.42 | $54K | 225,620 |
| 2025-02-22 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −40,650 | 81,301 | ||
| 2025-02-10 | Sachs David C. Chief Financial Officer | Grant or award · Restricted Stock Units | +246,710 | 246,710 | ||
| 2025-02-10 | Sachs David C. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +843,750 | 843,750 | ||
| 2024-12-31 | Sachs David C. Chief Financial Officer | Option exercise | +30,397 | 216,235 | ||
| 2024-12-31 | Sachs David C. Chief Financial Officer | Shares withheld for taxes | −15,405 | $2.56 | $39K | 200,830 |
| 2024-12-31 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −30,397 | 75,999 | ||
| 2024-02-22 | Sachs David C. Chief Financial Officer | Grant or award · Restricted Stock Units | +121,951 | 121,951 | ||
| 2024-02-22 | Sachs David C. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +424,390 | 424,390 | ||
| 2024-01-31 | Sachs David C. Chief Financial Officer | Option exercise | +70,745 | 212,673 |
Page 1 of 2 · 36 trades